International Thymic Malignancy Interest Group
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer
Correlation between Epidermal Growth Factor Receptor Mutations and Expression of Female Hormone Receptors in East-Asian Lung Adenocarcinomas
Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer
Prospective Study into the Incidence of Lambert Eaton Myasthenic Syndrome in Small Cell Lung Cancer
The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules
Verification of the Newly Proposed T Category (Seventh Edition of the Tumor, Node, and Metastasis Classification) from a Clinicopathological Viewpoint in Non-small Cell Lung Cancer—Special Reference to Tumor Size
A Novel Histopathological Evaluation Method Predicting the Outcome of Non-small Cell Lung Cancer Treated by Neoadjuvant Therapy
Video-Assisted Thoracic Surgery Lobectomy for Non-small Cell Lung Cancer in Patients with a Charlson Comorbidity Index Score of Two or More
Management of Multiple Primary Lung Cancer in Patients with Centrally Located Early Cancer Lesions
A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer
Phase I Trial of Intrapleural Docetaxel Administered Through an Implantable Catheter in Subjects with a Malignant Pleural Effusion
Octogenarians with Advanced Non-small Cell Lung Cancer
Chemotherapy-Associated Toxicity in a Large Cohort of Elderly Patients with Non-small Cell Lung Cancer
A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations
Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer
Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer
Primary Thymic Mucosa-Associated Lymphoid Tissue Lymphoma
Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil Combination Chemotherapy Against Metastatic Esophageal Squamous Cell Carcinoma
Antiangiogenic Agents and Vascular Disrupting Agents for the Treatment of Lung Cancer
Synchronous Pulmonary Renal Cell Carcinoma Metastases and Primary Non-small Cell Lung Cancer
Pericardial Varices Secondary to Superior Vena Cava Obstruction
A Hole in the Heart
Autofluorescence Imaging is Still Valuable Even in the Presence of a Peripheral Lung Lesion